Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cetrorelix vs dydrogesterone vs medroxyprogesterone acetate in poor ovarian response during IVF
IRCT20191104045328N37Phase 3Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Jun 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in poor ovarian response (POR) comparing Dydrogesterone + clomiphene citrate, Medroxyprogesterone acetate + clomiphene citrate and Cetrorelix acetate (3 arms). Primary endpoints: Number of retrieved oocytes, Two-pronuclei zygotes and 10 more. Started Jun 2025; status: completed.
02
Drugs
dydrogesteronemedroxyprogesterone acetatecetrorelix
03
Conditions
poor ovarian response (POR)
Beyond the preview
Go deeper on IRCT20191104045328N37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20191104045328N37.